HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Adriamycin activates NF-kappaB in human lung carcinoma cells by IkappaBalpha degradation.

Abstract
The aim of this study was to investigate the effect of adriamycin (ADR) in signaling activation of NF-kappaB in ADR-sensitive and -resistant GLC(4) human small-cell lung carcinoma. ADR activated NF-kappaB only in ADR-sensitive GLC(4) cells in a time- and dose-dependant manner by stimulating IkappaBalpha degradation after 4h. Activation of NF-kappaB in response to tumor necrosis factor was intact in both cell lines. Topoisomerase II, a target for a number of chemotherapeutic agents, was depleted in both types of GLC(4) cells after ADR treatment, suggesting the stabilization of transient DNA-topoisomerase II complexes. Another transcription factor, Sp1, was activated by ADR, demonstrating the nonspecificity of NF-kappaB activation in ADR-sensitive GLC(4) cells. These findings indicated that resistance to ADR in ADR-sensitive GLC(4) cells did not involve the NF-kappaB transcription factor.
AuthorsMaud Andriollo, Alain Favier, Pascale Guiraud
JournalArchives of biochemistry and biophysics (Arch Biochem Biophys) Vol. 413 Issue 1 Pg. 75-82 (May 01 2003) ISSN: 0003-9861 [Print] United States
PMID12706343 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, Neoplasm
  • Antineoplastic Agents
  • DNA-Binding Proteins
  • I-kappa B Proteins
  • NF-kappa B
  • NFKBIA protein, human
  • NF-KappaB Inhibitor alpha
  • Doxorubicin
  • DNA
  • CASP3 protein, human
  • Caspase 3
  • Caspases
  • DNA Topoisomerases, Type II
Topics
  • Antigens, Neoplasm
  • Antineoplastic Agents (pharmacology)
  • Base Sequence
  • Carcinoma, Small Cell (drug therapy, genetics, metabolism)
  • Caspase 3
  • Caspases (metabolism)
  • DNA (genetics)
  • DNA Topoisomerases, Type II (metabolism)
  • DNA-Binding Proteins
  • Doxorubicin (pharmacology)
  • Drug Resistance, Neoplasm
  • Humans
  • I-kappa B Proteins (metabolism)
  • Lung Neoplasms (drug therapy, genetics, metabolism)
  • NF-KappaB Inhibitor alpha
  • NF-kappa B (genetics, metabolism)
  • Signal Transduction (drug effects)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: